The effect of hypothermia in combination therapies for cerebral ischaemia: A review of animal trials

International Journal of Neuroprotection and Neuroregeneration

Volumn 3, Issue 3, 2007, Pages 210-224

  Campbell, Kamahl ^a,b   Meloni, Bruno P ^a   Knuckey, Neville W ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Cerebral ischaemia; Combination therapy; Hypothermia; Neuroprotection

Indexed keywords

CALCIUM; CANNABINOID RECEPTOR; CLOMETHIAZOLE; CYCLOSPORIN A; DIAZEPAM; DIPYRONE; GLUTAMATE CARBOXYPEPTIDASE II; MAGNESIUM; MANNITOL; METHOHEXITAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TACROLIMUS; TIRILAZAD;

BRAIN ISCHEMIA; CRANIECTOMY; DECOMPRESSION; HYPOTHERMIA; NEUROPROTECTION; NONHUMAN; REVIEW;

EID: 40549100334     PISSN: 17451183     EISSN: 17451191     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Mergenthaler P, Dirnagl U, and Meisel A. Pathophysiology of Stroke: Lessons From Animal Models. Metab Brain Dis 2004; 19 (3/4): 151-167
2. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development. Stroke 1999; 30: 2752-2758
3. Bernard SA, Gray TW, Buist MD et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346 (8): 557-563
4. FAST-MAG Update January 2007, http://www.fastmag.info/news.htm accessed 10th May, 2007
5. Schmid-Elsaesser R, Hungerhuber E, Zausinger S, Baethmann A, Reulen HJ. Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia. Stroke 1999; 30 (9): 1891-1899
6. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia. Neurosurgery 1999; 44 (1): 163-71
7. Zausinger S, Schöller K, Plesnila N and Schmid-Elsaesser R. Combination Drug Therapy and Mild Hypothermia After Transient Focal Cerebral Ischemia in Rats. Stroke 2003; 34: 2246-2251
8. Doerfler A, Schwab S, Hoffmann T, Engelhorn T and Forsting M. Combination of Decompressive Craniectomy and Mild Hypothermia Ameliorates Infarction Volume After Permanent Focal Ischemia in Rats. Stroke 2001; 32: 2675-2681
9. Berger C, Schabitz W-R, Wolf M, Mueller H, Sommer C and Schwab S. Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp Neurol. 2004; 185: 305-312
10. Aronowski J, Strong R, Shirzadi A and Grotta JC. Ethanol Plus Caffeine (Caffeinol) for Treatment of Ischemic Stroke: Preclinical Experience. Stroke 2003; 34: 1246-1251
11. Strong R, Grotta JC and Aronowski J. Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Neuropharmacology 2000; 39 (3): 515-22
12. Bonfils PK, Reith J, Hasseldam H, and Johansen FF. Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia. Neurochem Int 2006; 49: 508-518
13. Coimbra C, Drake M, Boris-Moller F and Wieloch T. Long-lasting Neuroprotective Effect of Postischemic Hypothermia and Treatment With an Anti-inflammatory/Antipyretic Drug. Evidence for Chronic Encephalopathic Processes Following Ischemia. Stroke 1996; 27: 1578-1585
14. Nito C, Kamiya T, Amemiya S, Katoh K and Katayama Y. The neuroprotective effect of a free radical scavenger and mild hypothermia following transient focal ischemia in rats. Acta Neurochir Suppl 2003; 86: 199-203
15. Kamiya T, Nito C, Ueda M et al. Mild hypothermia enhances the neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats. Acta Neurochir Suppl 2003; 86: 195-198
16. Green EJ, Pazos AJ, Dietrich WD et al. Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res 1995; 702: 145-152
17. Zhu H, Meloni BP, Bojarski C, Knuckey MW and Knuckey NW. Post-ischemic modest hypothermia (35°C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Exp Neurol 2005; 193: 361-368
18. Dietrich WD, Busto R, and Bethea JR. Postischemic Hypothermia and IL-10 Treatment Provide Long-Lasting Neuroprotection of CA1 Hippocampus Following Transient Global Ischemia in Rats. Exp Neurol 1999; 158: 444-450
19. Guan J, Gunn AJ, Sirimanne ES et al. The Window of Opportunity for Neuronal Rescue With Insulin-Like Growth Factor-1 After Hypoxia-Ischemia in Rats Is Critically Modulated by Cerebral Temperature During Recovery. J Cereb Blood Flow Metab 2000; 20: 513-519
20. Guan J, Williams CE, Gunning M, Mallard EC & Gluckman PD. The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J Cereb Blood Flow Metab 1993; 13: 609-616.
21. Zhu H, Meloni BP, Moore SR, Majda BT and Knuckey NW. Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia. Brain Res 2004; 1014: 53-60
22. Nito C, Kamiya T, Ueda M, Arii T and Katayama Y. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res 2004; 1008: 179-185
23. Meloni BP, Zhu H and Knuckey NW. Is magnesium neuroprotective following global and focal cerebral ischaemia? A review of published studies. Magnes Res 2006; 19 (2): 123-137
24. Torup L, Borsdal J and Sager T. Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia. Neurosci Lett 2003; 351: 173-176
25. Dowden J, Reid C, Dooley P and Corbett D. Diazepam-induced neuroprotection: dissociating the effects of hypothermia following global ischemia. Brain Res 1999; 829: 1-6
26. Davies LM, MacLellan CL, Corbett DR and Colbourne F. Post-ischemic diazepam does not reduce hippocampal CA1 injury and does not improve hypothermic neuroprotection after forebrain ischemia in gerbils. Brain Res 2004; 1013: 223-229
27. Chaulk D, Wells J, Evans S, Jackson D and Corbett D. Long-term effects of clomethiazole in a model of global ischemia. Exp Neurol 2003; 182: 476-482
28. Lyden P, Shuaib A, Ng K et al. Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results. Stroke 2002; 33: 122-128
29. Kollmar R, Henninger N, Bardutzky J, Schellinger PD, Schäbitz W-R and Schwab S. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke - An MRI study. Exp Neurol 2004; 190: 204-212
30. Pazos AJ, Green EJ, Busto R et al. Effects of combined postischemic hypothermia and delayed N-tert-butyl-a-pheylnitrone PBN administration on histopathological and behavioral deficits associated with transient global ischemia in rats. Brain Res 1999; 846: 186-195
31. Westermaier T, Zausinger S, Baethmann A, Steiger H-J and Schmid-Elsaesser R. No additional neuroprotection provided by barbiturate-induced burst suppression under mild hypothermic conditions in rats subjected to reversible focal ischemia. J Neurosurg 2000; 93: 835-844
32. Li P-A, He QP and Siesjö BK. Effects of intracarotid arterial injection of cyclosporin A and spontaneous hypothermia on brain damage incurred after a long period of global ischemia. Brain Res 2001; 890: 306-313
33. Van Hemelrijck An, Hachimi-Idrissi S, Sarre S, Ebinger G and Michotte Y. Neuroprotective effect of N-acetyl-aspartyl-glutamate in combination with mild hypothermia in the endothelin-1 rat model of focal cerebral ischaemia. J Neurochem 2005; 95: 1287-1297
34. Hayakawa K, Mishima K, Abe K et al. Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism. Neuroreport 2004; 15 (15): 2381-2385
35. Kazan S, Karasoy M, Baloglu H and Tuncer R. The Effect of Mild Hypothermia, Mannitol and Insulin-Induced Hypoglycaemia on Ischaemic Infarct Volume in the Early Period After Permanent Middle Cerebral Artery Occlusion in the Rat. Acta Neurochir (Wien) 1999; 141 (9): 979-987
36. Torup L, Møller A, Sager TN and Diemer NH. Neuroprotective effect of 8-OH-DPAT in global cerebral ischemia assessed by stereological cell counting. Eur J Pharmacol 2000; 395: 137-141
37. Chang ML, Yang J, Kem S et al.Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion. Neurosci Lett 2002; 322: 137-140
38. Gyertyán I, Gigler G and Simó A. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive -amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model. Brain Res Bull 1999; 50 (3): 179-186
39. Krieger DW and Yenari MA. Therapeutic Hypothermia for Acute Ischemic Stroke: What Do Laboratory Studies Teach Us? Stroke 2004; 35: 1482-1489
40. Schaller B and Graf R . Hypothermia and stroke: the pathophysiological background. Pathophysiology 2003; 10: 7-35
41. Hemmen TM and Lyden PD. Induced Hypothermia for Acute Stroke. Stroke 2007; 38: 794-799